CRISPR Therapeutics AG (CRSP) Financials
Key financial figures for CRISPR Therapeutics AG (Q2 2026).
- Revenue
- $10M
- Net Income
- -$91M
- EPS
- $-0.94
- Total Assets
- $2.7B
- Operating Cash Flow
- -$83M
Full income statement, balance sheet, and cash flow for CRISPR Therapeutics AG on SentiSense.